Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dikran Bairamian is active.

Publication


Featured researches published by Dikran Bairamian.


Neurology | 1985

Positron emission tomography in generalized seizures.

William H. Theodore; Rodney A. Brooks; Richard Margolin; Nicholas J. Patronas; Susumu Sato; Roger J. Porter; Luigi Mansi; Dikran Bairamian; Giovanni DiChiro

We used 1BF-fluorodeoxyglucose (FDG) positron emission tomography (PET) to study nine patients with clinical absence or generalized seizures. One patient had only absence seizures, two had only generalized tonic-clonic seizures, and six had both seizure types. Interictal scans in eight failed to reveal focal or lateralized hypometabolism. No apparent abnormalities were noted. Two patients had PET scans after isotope injection during hyperventilation-induced generalized spike-wave discharges. Diffusely increased metabolic rates were found in one compared with an interictal scan, and in another compared with control values. Another patient had FDG injected during absence status: EEG showed generalized spike-wave discharges (during which she was unresponsive) intermixed with slow activity accompanied by confusion. Metabolic rates were decreased, compared with the interictal scan, throughout both cortical and subcortical structures. Interictal PET did not detect specific anatomic regions responsible for absence seizure onset in any patient, but the results of the ictal scans did suggest that pathophysiologic differences exist between absence status and single absence attacks.


Brain Research | 1984

Depressed cerebellar glucose metabolism in supratentorial tumors

Nicholas J. Patronas; Giovanni Di Chiro; Barry H. Smith; Robert De La Paz; Rodney A. Brooks; Henry Milam; Paul L. Kornblith; Dikran Bairamian; Luigi Mansi

Fifty-four patients with supratentorial tumor and one with brainstem tumor were examined with positron emission tomography (PET) using [18F]fluoro-deoxyglucose (FDG). Twenty-one of these cases had satisfactory studies of the cerebellum. Of these, 12 showed significant metabolic asymmetry between the two cerebellar hemispheres, with the rate of glucose utilization in the hemisphere contralateral to the cerebral tumor being 8-34% lower than on the ipsilateral side, as compared with a right-left asymmetry of only--1.6% +/- 2.1% standard deviation for a group of 5 normal subjects. In these 12 cases the tumor involved the sensorimotor cortex and/or the thalamus with varying degrees of hemiparesis being present. For the remaining 9 patients with no significant cerebellar metabolic asymmetry, the tumor involved regions other than the sensorimotor cortex, and unilateral motor dysfunction was not a prominent clinical feature. The correlation between cerebellar metabolic suppression and unilateral motor dysfunction observed in our cases appears to be due to impairment or interruption of the cortico-thalamo-ponto-olivo-cerebellar circuitry by either the tumor itself or by edema. These results illustrate the ability of FDG-PET scans to detect metabolic changes, not apparent on CT scans, in areas of the brain remote from the primary lesion.


Journal of Cerebral Blood Flow and Metabolism | 1986

Effect of Phenytoin on Human Cerebral Glucose Metabolism

William H. Theodore; Dikran Bairamian; Michael E. Newmark; Giovanni DiChiro; Roger J. Porter; Steven M. Larson; Donn Fishbein

We used serial positron emission tomography scans with [18F]2-deoxyglucose to study the effect of phenytoin on human cerebral glucose metabolism in 10 patients with seizure disorders. Local CMRglu for each patient was measured in 10 regions of interest. EEGs were performed during each procedure to match scans for state of consciousness and exclude data from scans with ictal activity. Serial scans without a drug change were performed in six control patients. Metabolic rates were significantly lower in two cortical regions while patients were taking phenytoin. No significant changes on repeat scan were seen in the control population. Measured across all regions of interest, metabolic rates were 13% higher when patients were off phenytoin (p < 0.02).


Journal of Computer Assisted Tomography | 1985

MR imaging and positron emission tomography of cortical heterotopia

Dikran Bairamian; G. Di Chiro; William H. Theodore; Holmes; Robert Dorwart; S.M. Larson

Heterotopia of the gray matter is a developmental malformation in which ectopic cortex is found in the white matter of the brain. A case of a 33-year-old man with cortical heterotopia who had a lifelong history of seizures and psychomotor retardation is reported, including the results of cerebral CT, magnetic resonance imaging, and positron emission tomography using 18F-2-deoxyglucose.


Journal of Neurosurgery | 1985

Prediction of survival in glioma patients by means of positron emission tomography

Nicholas J. Patronas; Giovanni Di Chiro; Conrad V. Kufta; Dikran Bairamian; Paul L. Kornblith; Richard H. Simon; Steven M. Larson


Annals of Neurology | 1984

Issues in the in vivo measurement of glucose metabolism of human central nervous system tumors.

Giovanni Di Chiro; Rodney A. Brooks; Nicholas J. Patronas; Dikran Bairamian; Paul L. Kornblith; Barry H. Smith; Luigi Mansi; John Barker


Radiology | 1985

Tumors and arteriovenous malformations of the spinal cord: assessment using MR.

G. Di Chiro; J L Doppman; Andrew J. Dwyer; Nicholas J. Patronas; R H Knop; Dikran Bairamian; Michael Vermess; Edward H. Oldfield


The Journal of Nuclear Medicine | 1987

Test-Retest Studies of Cerebral Glucose Metabolism Using Fluorine-18 Deoxyglucose: Validation of Method

Rodney A. Brooks; Giovanni Di Chiro; Bruce Zukerberg; Dikran Bairamian; Steven M. Larson


Annals of Neurology | 1987

Cerebral glucose metabolism in the Lennox-Gastaut syndrome

William H. Theodore; Douglas F. Rose; Nicholas J. Patronas; Susumu Sato; Mark D. Holmes; Dikran Bairamian; Roger J. Porter; Giovanni Di Chiro; Steven M. Larson; Donn Fishbein


Journal of Computer Assisted Tomography | 1986

Pituitary adenoma with seizures: PET demonstration of reduced glucose utilization in the medial temporal lobe

Dikran Bairamian; G. Di Chiro; H. Blume; B. Ehrenberg

Collaboration


Dive into the Dikran Bairamian's collaboration.

Top Co-Authors

Avatar

Giovanni Di Chiro

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Nicholas J. Patronas

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Rodney A. Brooks

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

William H. Theodore

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Steven M. Larson

Memorial Sloan Kettering Cancer Center

View shared research outputs
Top Co-Authors

Avatar

G. Di Chiro

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Paul L. Kornblith

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Roger J. Porter

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

S.M. Larson

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Barry H. Smith

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge